Starting Adderall in an 11-Year-Old with New ADHD Symptoms
Begin with 5 mg once or twice daily in the morning, increasing by 5 mg weekly intervals based on clinical response, with a typical target range of 10-30 mg/day for most children this age 1.
Pre-Treatment Assessment
Before initiating Adderall, you must assess for cardiac risk factors through detailed personal and family history of sudden death, ventricular arrhythmia, or structural heart disease 2. If risk factors are present, obtain an ECG before starting treatment. Also evaluate for motor/verbal tics or Tourette's syndrome, as stimulants can exacerbate these conditions 1.
Initial Dosing Strategy
For children 6 years and older (which includes your 11-year-old patient), the FDA-approved starting dose is 5 mg once or twice daily 1. Give the first dose upon awakening. If using twice-daily dosing, space additional doses 4-6 hours apart, avoiding late evening administration to prevent insomnia 1.
Dose Titration
Increase the dose in 5 mg increments at weekly intervals until you achieve optimal symptom control 1. This weekly titration allows adequate time to assess both efficacy and tolerability at each dose level. The evidence shows dose-dependent improvements in ADHD symptoms, with higher doses generally providing greater benefit up to the maximum recommended dose 3, 4.
Rarely will doses exceed 40 mg/day be necessary 1. Most children achieve optimal response between 10-30 mg/day, though individual variability is substantial 5. The goal is the lowest effective dose that provides meaningful symptom improvement.
Monitoring Parameters
Track these parameters at each visit:
Height and weight: Stimulants cause growth attenuation, particularly in the first 1-2 years of treatment 2. Children on higher doses show more pronounced effects (Δ height z-score -0.41, Δ weight z-score -0.56) 6.
Blood pressure and pulse: Expect modest increases (mean increases of 3-5 mmHg systolic BP and 5-6 bpm pulse) 4. Monitor at each dose adjustment.
Appetite and sleep: The most common adverse effects are decreased appetite (35.6% vs 1.9% placebo), insomnia (12%), and headache (16%) 3. These are typically mild to moderate and often improve with dose adjustment or timing changes.
Behavioral response: Use standardized rating scales (ADHD-RS-IV or similar) to objectively track symptom improvement. Expect to see significant improvements (>30% reduction in symptom scores) within 1-2 weeks at an effective dose 7.
Expected Timeline and Effects
Stimulants have rapid onset of action—you should observe behavioral improvements within 1.5 hours of the first dose, with peak effects at 7-8 hours post-dose for extended-release formulations 8, 9. If you see no improvement after 2-3 weeks at an adequate dose (≥20 mg/day for most school-age children), consider switching to a different stimulant class (methylphenidate) rather than continuing to escalate the amphetamine dose 10.
Common Pitfalls to Avoid
Don't underdose: Many children require 20-30 mg/day for optimal response. The evidence shows clear dose-response relationships, with 20-40 mg doses significantly more effective than 10 mg 3.
Don't abruptly discontinue: While not as critical as with alpha-2 agonists, establish a plan for consistent daily dosing rather than intermittent use during initial titration.
Don't ignore growth: Weight loss and growth deceleration occur early in treatment. If significant (>1 z-score decline), consider drug holidays on weekends/summers or switching medications 2.
Don't overlook cardiac symptoms: Any chest pain, syncope, or palpitations requires immediate evaluation and likely medication discontinuation 1.
Special Considerations for This Age Group
At 11 years old, this patient falls squarely in the age range with the strongest evidence for stimulant efficacy and safety 10. Stimulants are first-line pharmacotherapy for school-age children with moderate-to-severe ADHD 10. The decision to start medication should be based on symptom severity, functional impairment across multiple settings (home and school), and inadequate response to behavioral interventions alone 10.
Adderall (mixed amphetamine salts) and methylphenidate have comparable large effect sizes (0.65-0.80) for core ADHD symptoms 4. The choice between them is often based on individual response, tolerability, and duration of coverage needed. Extended-release formulations provide 10-12 hours of symptom control with once-daily dosing, eliminating the need for school administration 7, 8.
Substance Control Considerations
Adderall is a Schedule II controlled substance with abuse potential 1. Counsel families about secure storage, proper disposal of unused medication, and never sharing with others. Monitor for signs of misuse, though this is less concerning in pre-adolescent children than in teenagers 1.